INDBInternet News Database 2.5 Updated 1 min ago · 297 sources Show or hide images Light or dark

Lenalidomide Plus RT Linked to Longer PFS in Plasmacytoma

Save Like Comments Compare coverage

Summary

In a small retrospective study, adding lenalidomide-dexamethasone to RT was associated with higher 10-year PFS in solitary plasmacytoma. However, multiple myeloma-free survival did not differ significantly between groups. Medscape Medical News

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Lenalidomide Plus RT Linked to Longer PFS in Plasmacytoma

    In a small retrospective study, adding lenalidomide-dexamethasone to RT was associated with higher 10-year PFS in solitary plasmacytoma. However, multiple myeloma-free survival did not differ significantly between groups. Medscape Medical News

Comments

Comments need JavaScript.